SHRAX | VTSAX | SHRAX / VTSAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 41 years | 24 years | - |
Gain YTD | -5.245 | 22.422 | -23% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.58B | 1.84T | 0% |
Annual Yield % from dividends | 0.12 | 1.35 | 9% |
Returns for 1 year | -5.04 | 22.05 | -23% |
Returns for 3 years | -31.14 | 23.87 | -130% |
Returns for 5 years | -43.32 | 77.49 | -56% |
Returns for 10 years | -51.62 | 183.58 | -28% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFCX | 12.60 | 0.02 | +0.16% |
AlphaCentric Life Sciences & Hlthcare C | |||
PEPSX | 26.34 | N/A | N/A |
Principal Glb Emerging Markets R5 | |||
FRRSX | 17.33 | -0.06 | -0.35% |
Franklin Real Estate Securities C | |||
BSMAX | 17.49 | -0.19 | -1.07% |
iShares Russell Small/Mid-Cap Idx Inv A | |||
EISMX | 41.71 | -1.35 | -3.14% |
Eaton Vance Atlanta Capital SMID-Cap I |